Literature DB >> 22790832

Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference?

Chanita Hughes Halbert1, Lisa Kessler, Aliya Collier, Benita Weathers, Jill Stopfer, Susan Domchek, Jasmine A McDonald.   

Abstract

Low rates of genetic counseling among African American women have generated concerns about disparities; however, to the extent that women's decisions to accept or decline counseling are consistent with their values, then lower participation may reflect preferences and not disparities. We evaluated the extent to which women were satisfied with their decision about participating in genetic counseling for BRCA1/2 mutations and identified variables that were associated significantly with satisfaction. Prospective study of decision satisfaction with 135 African American women who had a minimum 5% prior probability of having a BRCA1/2 mutation. Decision satisfaction was evaluated one month after women were offered participation in genetic counseling using a structured questionnaire. Women were satisfied with their participation decision; more than 80% reported that their decision was consistent with their family values. However, women who declined pre-test counseling had significantly lower satisfaction scores. Our findings highlight the importance ensuring that racial differences that are due to preferences and values are not misclassified as disparities in order to identify and address the root causes of disparate treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22790832      PMCID: PMC3773724          DOI: 10.1007/s10897-012-9485-y

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

1.  Health disparities research: exploring different research pathways.

Authors:  Willa Doswell
Journal:  Res Nurs Health       Date:  2002-04       Impact factor: 2.228

2.  Sociocultural influences on participation in genetic risk assessment and testing among African American women.

Authors:  Chanita Hughes; Grace Ann Fasaye; V Holland LaSalle; Clinton Finch
Journal:  Patient Educ Couns       Date:  2003-10

Review 3.  Promoting informed decisions about cancer screening in communities and healthcare systems.

Authors:  Peter Briss; Barbara Rimer; Barbara Reilley; Ralph C Coates; Nancy C Lee; Patricia Mullen; Phaedra Corso; Angela B Hutchinson; Robert Hiatt; Jon Kerner; Prethibha George; Cornelia White; Nisha Gandhi; Mona Saraiya; Rosalind Breslow; George Isham; Steven M Teutsch; Alan R Hinman; Robert Lawrence
Journal:  Am J Prev Med       Date:  2004-01       Impact factor: 5.043

4.  Health disparities research--a model for conducting research on cancer disparities: characterization and reduction.

Authors:  Claudia R Baquet; Camille Hammond; Patricia Commiskey; Sandra Brooks; C Daniel Mullins
Journal:  J Assoc Acad Minor Phys       Date:  2002-04

5.  The concept of access: definition and relationship to consumer satisfaction.

Authors:  R Penchansky; J W Thomas
Journal:  Med Care       Date:  1981-02       Impact factor: 2.983

6.  Spiritual faith and genetic testing decisions among high-risk breast cancer probands.

Authors:  M D Schwartz; C Hughes; J Roth; D Main; B N Peshkin; C Isaacs; C Kavanagh; C Lerman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-04       Impact factor: 4.254

Review 7.  Application of breast cancer risk prediction models in clinical practice.

Authors:  Susan M Domchek; Andrea Eisen; Kathleen Calzone; Jill Stopfer; Anne Blackwood; Barbara L Weber
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

8.  The effect of patient race and socio-economic status on physicians' perceptions of patients.

Authors:  M van Ryn; J Burke
Journal:  Soc Sci Med       Date:  2000-03       Impact factor: 4.634

9.  BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.

Authors:  C Lerman; S Narod; K Schulman; C Hughes; A Gomez-Caminero; G Bonney; K Gold; B Trock; D Main; J Lynch; C Fulmore; C Snyder; S J Lemon; T Conway; P Tonin; G Lenoir; H Lynch
Journal:  JAMA       Date:  1996-06-26       Impact factor: 56.272

10.  Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

Authors:  Hayley S Thompson; Heiddis B Valdimarsdottir; Chantal Duteau-Buck; Josephine Guevarra; Dana H Bovbjerg; Cassandra Richmond-Avellaneda; David Amarel; Diana Godfrey; Karen Brown; Kenneth Offit
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

View more
  23 in total

1.  Effects of a genetic counseling model on mothers of children with down syndrome: a Brazilian pilot study.

Authors:  Marcos Ricardo Datti Micheletto; Nelson Iguimar Valerio; Agnes Cristina Fett-Conte
Journal:  J Genet Couns       Date:  2013-06-23       Impact factor: 2.537

Review 2.  Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Authors:  Christina D Williams; Alyssa Jasmine Bullard; Meghan O'Leary; Reana Thomas; Thomas S Redding; Karen Goldstein
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-08

Review 3.  A Rapid Systematic Review of Outcomes Studies in Genetic Counseling.

Authors:  Lisa Madlensky; Angela M Trepanier; Deborah Cragun; Barbara Lerner; Kristen M Shannon; Heather Zierhut
Journal:  J Genet Couns       Date:  2017-02-06       Impact factor: 2.537

4.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

5.  Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care.

Authors:  Vivian M Rodríguez; Erika Robers; Kate Zielaskowski; C Javier González; Keith Hunley; Kimberly A Kaphingst; Dolores D Guest; Andrew Sussman; Kirsten A Meyer White; Matthew R Schwartz; Jennie Greb; Yvonne Talamantes; Jessica Bigney; Marianne Berwick; Jennifer L Hay
Journal:  J Community Genet       Date:  2016-12-06

6.  The Role of Knowledge on Genetic Counseling and Testing in Black Cancer Survivors at Increased Risk of Carrying a BRCA1/2 Mutation.

Authors:  Alejandra Hurtado-de-Mendoza; Monica C Jackson; Lyndsay Anderson; Vanessa B Sheppard
Journal:  J Genet Couns       Date:  2016-07-12       Impact factor: 2.537

7.  Discussing race-related limitations of genomic testing for colon cancer risk: implications for education and counseling.

Authors:  Morgan N Butrick; Lauren Vanhusen; Kara-Grace Leventhal; Gillian W Hooker; Rachel Nusbaum; Beth N Peshkin; Yasmin Salehizadeh; Jessica Pavlick; Marc D Schwartz; Kristi D Graves
Journal:  Soc Sci Med       Date:  2014-05-15       Impact factor: 4.634

8.  Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.

Authors:  Samfee Doe; Shariska Petersen; Monique Swain
Journal:  Breast J       Date:  2020-01-09       Impact factor: 2.431

9.  Effective Referral of Low-Income Women at Risk for Hereditary Breast and Ovarian Cancer to Genetic Counseling: A Randomized Delayed Intervention Control Trial.

Authors:  Rena J Pasick; Galen Joseph; Susan Stewart; Celia Kaplan; Robin Lee; Judith Luce; Sharon Davis; Titas Marquez; Tung Nguyen; Claudia Guerra
Journal:  Am J Public Health       Date:  2016-08-23       Impact factor: 9.308

10.  Development and Pilot Testing of a Decision Aid for Genomic Research Participants Notified of Clinically Actionable Research Findings for Cancer Risk.

Authors:  Amanda M Willis; Sian K Smith; Bettina Meiser; Mandy L Ballinger; David M Thomas; Martin Tattersall; Mary-Anne Young
Journal:  J Genet Couns       Date:  2018-02-17       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.